✦ LIBER ✦

Hospitalization rates associated with olanzapine, risperidone, and haloperidol treatment in patients with schizophrenia: Results from a U.S. randomized controlled trial

✍ Scribed by M. Namjoshi; C. Young; L. Huang; E.T. Edgell; A. Breier

Book ID: 119576228
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 127 KB
Volume: 12
Category: Article
ISSN: 0924-977X
DOI: 10.1016/s0924-977x(02)80471-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-effectiveness of olanzapine compare

Cost-effectiveness of olanzapine compared to risperidone and haloperidol in the treatment of patients with schizophrenia: Results from a U.S. randomized controlled trial

✍ M. Namjoshi; C.A. Young; L. Huang; E. Edgell; A. Breier 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 123 KB

Economic, clinical, and quality-of-life

Economic, clinical, and quality-of-life outcomes associated with olanzapine treatment in mania: Results from a randomized controlled trial

✍ Madhav A Namjoshi; Gopalan Rajamannar; Thomas Jacobs; Todd M Sanger; Richard Ris 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 79 KB

PMH12 24-MONTH TREATMENT DISCONTINUATION

PMH12 24-MONTH TREATMENT DISCONTINUATION RATES IN PATIENTS WITH SCHIZOPHRENIA TREATED WITH RISPERIDONE LONG ACTING INJECTION (RLAI) VERSUS ORAL ANTIPSYCHOTICS: RESULTS FROM THE ELECTRONIC SCHIZOPHRENIA TREATMENT ADHERENCE REGISTRY (E-STAR) IN SPAIN

✍ JM Olivares; JK Diels; A Rodriguez-Morales; Z Zhao; A Lam 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

Adalimumab treatment is associated with

Adalimumab treatment is associated with pain reduction in patients with hidradenitis suppurativa, regardless of the presence of depression: Results from a phase II, randomized, placebo-controlled trial

📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 79 KB

PMH40 12-MONTH TREATMENT DISCONTINUATION

PMH40 12-MONTH TREATMENT DISCONTINUATION RATES IN PATIENTS WITH SCHIZOPHRENIA TREATED WITH RISPERIDONE LONG ACTING INJECTION (RLAI): INTERIM RESULTS FROM THE ELECTRONIC SCHIZOPHRENIA TREATMENT ADHERENCE REGISTRY PROJECT CONDUCTED IN SPAIN, AUSTRALIA AND BELGIUM

✍ JM Olivares; B Emmerson; J Peuskens; JK Diels; S Caleo; M Povey; A Lam 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

Cabergoline compared to levodopa in the

Cabergoline compared to levodopa in the treatment of patients with severe restless legs syndrome: Results from a multi-center, randomized, active controlled trial

✍ Claudia Trenkwalder; Heike Benes; Ludger Grote; Svenja Happe; Birgit Högl; Johan 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB 👁 1 views

## Abstract We report the first large‐scale double‐blind, randomly assigned study to compare two active dopaminergic therapies for Restless Legs Syndrome (RLS), the dopamine agonist cabergoline (CAB) and levodopa/benserazide (levodopa). Patients with idiopathic RLS were treated with fixed daily dos